Schedule 13D ownership disclosure

ContraVir Pharmaceuticals, Inc.

Security class unavailable

Event date: 2018-02-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,463,579
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-011748
Form type
SC 13D
Filer
CERRONE GABRIEL
CIK
CIK 1253803
Filed
Feb 23, 2018
Reporting period
Feb 22, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub